Chronic Administration of Small Nonerythropoietic Peptide Sequence of Erythropoietin Effectively Ameliorates the Progression of Postmyocardial Infarction–Dilated Cardiomyopathy

The cardioprotective properties of erythropoietin (EPO) in preclinical studies are well documented, but erythropoietic and prothrombotic properties of EPO preclude its use in chronic heart failure (CHF). We tested the effect of long-term treatment with a small peptide sequence within the EPO molecul...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ahmet, Ismayil, Tae, Hyun-Jin, Brines, Michael, Cerami, Anthony, Lakatta, Edward G., Talan, Mark I.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The American Society for Pharmacology and Experimental Therapeutics 2013
Onderwerpen:
Drug Discovery and Translational Medicine
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3657107/
https://ncbi.nlm.nih.gov/pubmed/23584743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.113.202945
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items